VNARs antibodies (Ossianix)

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameVNARs antibodies (Ossianix)
Drug Alias Nameanti-SARS-CoV-2 spike protein single domain shark antibodies (Ossianix)COVID19 Spike glycoprotein inhibitor (Ossianix)
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody
Mechanisms of ActionCoronavirus spike glycoprotein inhibitors
TargetsCoronavirus spike glycoprotein
Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesOssianix Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesOssianix Inc
Active IndicationsN/A
Inactive IndicationsCoronavirus Disease 2019 (COVID-19)

Other Information

ATC CodeN/A
Related LinksN/A